Literature DB >> 26306711

NSAIDs and cardiovascular disease: time to say no to diclofenac.

Patompong Ungprasert1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26306711     DOI： 10.1007/s11739-015-1295-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  14 in total

Review 1.  Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.

Authors:  C Patrono; P Patrignani; L A García Rodríguez
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

Review 3.  Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies.

Authors:  Patompong Ungprasert; Wisit Cheungpasitporn; Cynthia S Crowson; Eric L Matteson
Journal:  Eur J Intern Med       Date:  2015-04-08       Impact factor: 4.487

4.  Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.

Authors:  W G Bensen; S Z Zhao; T A Burke; R A Zabinski; R W Makuch; C J Maurath; N M Agrawal; G S Geis
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

5.  Association of short-term use of nonsteroidal anti-inflammatory drugs with stroke in patients with hypertension.

Authors:  Shao-Yuan Chuang; Yunxian Yu; Wayne Huey-Herng Sheu; Yu-Ting Tsai; Xin Liu; Chao A Hsiung; Hui-Ju Tsai
Journal:  Stroke       Date:  2015-03-03       Impact factor: 7.914

6.  Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.

Authors:  Dirk O Stichtenoth; Verena Marhauer; Dimitrios Tsikas; Frank-Mathias Gutzki; Jürgen C Frölich
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

7.  Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study.

Authors:  P García-Poza; F J de Abajo; M J Gil; A Chacón; V Bryant; L A García-Rodríguez
Journal:  J Thromb Haemost       Date:  2015-02-24       Impact factor: 5.824

8.  Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.

Authors:  J Graff; C Skarke; U Klinkhardt; B Watzer; S Harder; H Seyberth; G Geisslinger; R M Nüsing
Journal:  J Thromb Haemost       Date:  2007-10-03       Impact factor: 5.824

9.  Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women.

Authors:  Gary C Curhan; Andrea J Bullock; Susan E Hankinson; Walter C Willett; Frank E Speizer; Meir J Stampfer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-12       Impact factor: 2.890

Review 10.  Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema?

Authors:  Ashish Aneja; Michael E Farkouh
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-02
View more
  1 in total

Review 1.  Anti-CGRP monoclonal antibodies in migraine: current perspectives.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Martina Curto; Andrea Negro; Raffaele Costantini; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2016-06-23       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.